Who We Are

Aeris Therapeutics is dedicated to the development and commercialization of innovative therapies that improve the lives of patients with emphysema and other advanced lung diseases. We pursue this mission by maintaining our commitment to scientific excellence and the highest quality standards. Our company possesses a fundamental core competence in pulmonary medicine with substantial capabilities in preclinical and clinical research, product development and commercialization.

We are committed to investing in research and development and fueling innovation, delivering novel products resulting in outstanding value to patients, customers, and stakeholders.

Total quality is vital to our business.  We are committed to meeting customer and regulatory requirements and maintaining the effectiveness of the quality management system.

Aeris Therapeutics is privately held, with corporate offices in Woburn, MA.